XML 32 R20.htm IDEA: XBRL DOCUMENT v3.25.2
(Loss) Earnings per Share
6 Months Ended
Jun. 30, 2025
Earnings Per Share [Abstract]  
(Loss) Earnings per Share Loss per Share
The following table presents a reconciliation of the numerator and denominator of basic and diluted loss per share for the three and six months ended June 30, 2025 and 2024, respectively:
Three Months Ended
 June 30,
Six Months Ended
 June 30,
2025202420252024
(Dollars in thousands, except per share amounts)
Numerator for basic and diluted loss per share:
Net loss$(86,886)$(14,752)$(126,237)$(45,621)
Denominator:
Weighted average common shares outstanding for basic calculation259,183,478 257,772,069 258,779,643 257,587,613 
Weighted average common shares outstanding for diluted calculation259,183,478 257,772,069 258,779,643 257,587,613 
Basic loss per share$(0.34)$(0.06)$(0.49)$(0.18)
Diluted loss per share$(0.34)$(0.06)$(0.49)$(0.18)
Basic loss per share is calculated by dividing net loss by the weighted average number of common shares outstanding. Diluted loss per share is calculated by dividing net loss by the sum of the weighted average number of common shares outstanding plus the additional common shares that would have been outstanding if potentially dilutive securities had been issued.
The weighted average common shares outstanding for the diluted loss per share calculation for the three and six months ended June 30, 2025 excludes the dilutive effect of approximately 289,651 shares and 281,620 shares, respectively, and 2,543 shares and 1,490 shares for the three and six months ended June 30, 2024, respectively, primarily related to restricted stock units (“RSUs”), as their inclusion would have been anti-dilutive due to the Company’s net loss.
Additionally, the weighted average common shares outstanding for the diluted loss per share calculation excludes consideration of 7,440,245 and 6,704,650 equivalent shares for the three and six months ended June 30, 2025, respectively, and 5,671,092 and 4,574,726 equivalent shares for the three and six months ended June 30, 2024, respectively, as their effect would have been anti-dilutive.